Biomarkers Industry Research Report 2023

Biomarkers Industry Research Report 2023


In biological system, it means to calculate the whole number by marking part of individuals.

Highlights

The global Biomarkers market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarkers.
The Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biomarkers market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies

Product Type Insights

Global markets are presented by Biomarkers type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Biomarkers are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Biomarkers segment by Type

Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biomarkers market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biomarkers market.
Biomarkers Segment by Application

Diagnostics
Drug Discovery
Personalized Medicine
Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biomarkers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biomarkers industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarkers.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Biomarkers by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
2.3 Biomarkers by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Diagnostics
2.3.3 Drug Discovery
2.3.4 Personalized Medicine
2.3.5 Other
2.4 Assumptions and Limitations
3 Biomarkers Breakdown Data by Type
3.1 Global Biomarkers Historic Market Size by Type (2018-2023)
3.2 Global Biomarkers Forecasted Market Size by Type (2023-2028)
4 Biomarkers Breakdown Data by Application
4.1 Global Biomarkers Historic Market Size by Application (2018-2023)
4.2 Global Biomarkers Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Biomarkers Market Perspective (2018-2029)
5.2 Global Biomarkers Growth Trends by Region
5.2.1 Global Biomarkers Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Biomarkers Historic Market Size by Region (2018-2023)
5.2.3 Biomarkers Forecasted Market Size by Region (2024-2029)
5.3 Biomarkers Market Dynamics
5.3.1 Biomarkers Industry Trends
5.3.2 Biomarkers Market Drivers
5.3.3 Biomarkers Market Challenges
5.3.4 Biomarkers Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Biomarkers Players by Revenue
6.1.1 Global Top Biomarkers Players by Revenue (2018-2023)
6.1.2 Global Biomarkers Revenue Market Share by Players (2018-2023)
6.2 Global Biomarkers Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Biomarkers Head office and Area Served
6.4 Global Biomarkers Players, Product Type & Application
6.5 Global Biomarkers Players, Date of Enter into This Industry
6.6 Global Biomarkers Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Biomarkers Market Size (2018-2029)
7.2 North America Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Biomarkers Market Size by Country (2018-2023)
7.4 North America Biomarkers Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Biomarkers Market Size (2018-2029)
8.2 Europe Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Biomarkers Market Size by Country (2018-2023)
8.4 Europe Biomarkers Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Biomarkers Market Size (2018-2029)
9.2 Asia-Pacific Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Biomarkers Market Size by Country (2018-2023)
9.4 Asia-Pacific Biomarkers Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Biomarkers Market Size (2018-2029)
10.2 Latin America Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Biomarkers Market Size by Country (2018-2023)
10.4 Latin America Biomarkers Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Biomarkers Market Size (2018-2029)
11.2 Middle East & Africa Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Biomarkers Market Size by Country (2018-2023)
11.4 Middle East & Africa Biomarkers Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Biomarkers Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Biomarkers Introduction
11.2.4 Merck Revenue in Biomarkers Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Biomarkers Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Biomarkers Introduction
11.4.4 QIAGEN Revenue in Biomarkers Business (2017-2022)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Biomarkers Introduction
11.5.4 Roche Revenue in Biomarkers Business (2017-2022)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Biomarkers Business (2017-2022)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Detail
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Biomarkers Business (2017-2022)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Biomarkers Introduction
11.8.4 Abbott Revenue in Biomarkers Business (2017-2022)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Biomarkers Business (2017-2022)
11.9.5 Agilent Technologies Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Biomarkers Revenue Market Share by Type (2018-2023)
Table 7. Global Biomarkers Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Biomarkers Revenue Market Share by Type (2024-2029)
Table 9. Global Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Biomarkers Revenue Market Share by Application (2018-2023)
Table 11. Global Biomarkers Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Biomarkers Revenue Market Share by Application (2024-2029)
Table 13. Global Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Biomarkers Market Share by Region (2018-2023)
Table 16. Global Biomarkers Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Biomarkers Market Share by Region (2024-2029)
Table 18. Biomarkers Market Trends
Table 19. Biomarkers Market Drivers
Table 20. Biomarkers Market Challenges
Table 21. Biomarkers Market Restraints
Table 22. Global Top Biomarkers Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Biomarkers Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Biomarkers Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Biomarkers, Headquarters and Area Served
Table 26. Global Biomarkers Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Biomarkers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Biomarkers Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Biomarkers Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Biomarkers Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Biomarkers Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Biomarkers Market Size by Country (2024-2029) & (US$ Million)
Table 45. Thermo Fisher Scientific Company Detail
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Biomarkers Product
Table 48. Thermo Fisher Scientific Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 49. Thermo Fisher Scientific Recent Development
Table 50. Merck Company Detail
Table 51. Merck Business Overview
Table 52. Merck Biomarkers Product
Table 53. Merck Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 54. Merck Recent Development
Table 55. Bio-Rad Laboratories Company Detail
Table 56. Bio-Rad Laboratories Business Overview
Table 57. Bio-Rad Laboratories Biomarkers Product
Table 58. Bio-Rad Laboratories Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 59. Bio-Rad Laboratories Recent Development
Table 60. QIAGEN Company Detail
Table 61. QIAGEN Business Overview
Table 62. QIAGEN Biomarkers Product
Table 63. QIAGEN Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 64. QIAGEN Recent Development
Table 65. Roche Company Detail
Table 66. Roche Business Overview
Table 67. Roche Biomarkers Product
Table 68. Roche Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Danaher Corporation Company Detail
Table 71. Danaher Corporation Business Overview
Table 72. Danaher Corporation Biomarkers Product
Table 73. Danaher Corporation Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 74. Danaher Corporation Recent Development
Table 75. Siemens Healthcare Company Detail
Table 76. Siemens Healthcare Business Overview
Table 77. Siemens Healthcare Biomarkers Product
Table 78. Siemens Healthcare Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 79. Siemens Healthcare Recent Development
Table 80. Abbott Company Detail
Table 81. Abbott Business Overview
Table 82. Abbott Biomarkers Product
Table 83. Abbott Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 84. Abbott Recent Development
Table 85. Agilent Technologies Company Detail
Table 86. Agilent Technologies Business Overview
Table 87. Agilent Technologies Biomarkers Product
Table 88. Agilent Technologies Revenue in Biomarkers Business (2017-2022) & (US$ Million)
Table 89. Agilent Technologies Recent Development
Table 90. Thermo Fisher Scientific Company Information
Table 91. Thermo Fisher Scientific Business Overview
Table 92. Thermo Fisher Scientific Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 93. Thermo Fisher Scientific Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 94. Thermo Fisher Scientific Recent Development
Table 95. Merck Company Information
Table 96. Merck Business Overview
Table 97. Merck Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 98. Merck Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 99. Merck Recent Development
Table 100. Bio-Rad Laboratories Company Information
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 103. Bio-Rad Laboratories Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 104. Bio-Rad Laboratories Recent Development
Table 105. QIAGEN Company Information
Table 106. QIAGEN Business Overview
Table 107. QIAGEN Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 108. QIAGEN Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 109. QIAGEN Recent Development
Table 110. Roche Company Information
Table 111. Roche Business Overview
Table 112. Roche Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 113. Roche Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 114. Roche Recent Development
Table 115. Danaher Corporation Company Information
Table 116. Danaher Corporation Business Overview
Table 117. Danaher Corporation Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 118. Danaher Corporation Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 119. Danaher Corporation Recent Development
Table 120. Siemens Healthcare Company Information
Table 121. Siemens Healthcare Business Overview
Table 122. Siemens Healthcare Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 123. Siemens Healthcare Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 124. Siemens Healthcare Recent Development
Table 125. Abbott Company Information
Table 126. Abbott Business Overview
Table 127. Abbott Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 128. Abbott Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 129. Abbott Recent Development
Table 130. Agilent Technologies Company Information
Table 131. Agilent Technologies Business Overview
Table 132. Agilent Technologies Biomarkers Revenue in Biomarkers Business (2018-2023) & (US$ Million)
Table 133. Agilent Technologies Revenue in Biomarkers Business (2018-2023) & (US$ Million) Portfolio
Table 134. Agilent Technologies Recent Development
Table 135. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Biomarkers Product Picture
Figure 5. Global Biomarkers Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Biomarkers Market Share by Type: 2022 VS 2029
Figure 7. Sepsis Biomarkers Product Picture
Figure 8. Antibiotic Resistance Biomarkers Product Picture
Figure 9. Traumatic Brain Injury (TBI) Testing Biomarkers Product Picture
Figure 10. Stroke Testing Biomarkers Product Picture
Figure 11. Antibiotic Stewardship Biomarkers Product Picture
Figure 12. Other Product Picture
Figure 13. Global Biomarkers Market Size by Application (2023-2029) & (US$ Million)
Figure 14. Global Biomarkers Market Share by Application: 2022 VS 2029
Figure 15. Diagnostics Product Picture
Figure 16. Drug Discovery Product Picture
Figure 17. Personalized Medicine Product Picture
Figure 18. Other Product Picture
Figure 19. Global Biomarkers Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Biomarkers Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Biomarkers Market Share by Region: 2022 VS 2029
Figure 22. Global Biomarkers Market Share by Players in 2022
Figure 23. Global Biomarkers Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Biomarkers Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Biomarkers Market Share by Country (2018-2029)
Figure 28. United States Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Biomarkers Market Share by Country (2018-2029)
Figure 32. Germany Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Biomarkers Market Share by Country (2018-2029)
Figure 40. China Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Biomarkers Market Share by Country (2018-2029)
Figure 48. Mexico Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Biomarkers Market Share by Country (2018-2029)
Figure 52. Turkey Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 56. Merck Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 58. QIAGEN Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 60. Danaher Corporation Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 61. Siemens Healthcare Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 62. Abbott Revenue Growth Rate in Biomarkers Business (2018-2023)
Figure 63. Agilent Technologies Revenue Growth Rate in Biomarkers Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings